Key result
Mutation of Thr29 in the human voltage-gated proton channel H(V)1 abolished the enhancement of proton channel gating by phorbol myristate acetate, indicating it is a critical phosphorylation site.
Direct phosphorylation of the proton channel molecule at Thr29 is crucial for activating proton conductance during the respiratory burst in phagocytes.
Does not alter clinical practice; extends mechanistic understanding of H(V)1 in phagocytes but leaves open in vivo validation.
Voltage-gated proton channels and NADPH oxidase function cooperatively in phagocytes during the respiratory burst, when reactive oxygen species are produced to kill microbial invaders. Agents that activate NADPH oxidase also enhance proton channel gating profoundly, facilitating its roles in charge compensation and pH(i) regulation. The "enhanced gating mode" appears to reflect protein kinase C (PKC) phosphorylation. Here we examine two candidates for PKC-delta phosphorylation sites in the human voltage-gated proton channel, H(V)1 (Hvcn1), Thr(29) and Ser(97), both in the intracellular N terminus. Channel phosphorylation was reduced in single mutants S97A or T29A, and further in the double mutant T29A/S97A, by an in vitro kinase assay with PKC-delta. Enhanced gating was evaluated by expressing wild-type (WT) or mutant H(V)1 channels in LK35.2 cells, a B cell hybridoma. Stimulation by phorbol myristate acetate enhanced WT channel gating, and this effect was reversed by treatment with the PKC inhibitor GF109203X. The single mutant T29A or double mutant T29A/S97A failed to respond to phorbol myristate acetate or GF109203X. In contrast, the S97A mutant responded like cells transfected with WT H(V)1. We conclude that under these conditions, direct phosphorylation of the proton channel molecule at Thr(29) is primarily responsible for the enhancement of proton channel gating. This phosphorylation is crucial to activation of the proton conductance during the respiratory burst in phagocytes.
No takes yet. Share an insight, caveat, or question.
Musset et al. (2009) studied this question. Mutation of Thr29 and Ser97 in human voltage-gated proton channel H(V)1 vs. Wild-type H(V)1 channels was evaluated on Channel phosphorylation and enhanced gating in response to phorbol myristate acetate. Mutation of Thr29 in the human voltage-gated proton channel H(V)1 abolished the enhancement of proton channel gating by phorbol myristate acetate, indicating it is a critical phosphorylation site.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: